Application progress of thrombolytic therapy in cardiopulmonary resus-citation

Abstract

Abstract: Thrombolytic therapy was constantly re-garded as relative contraindication in cardiopulmonary resuscitation(CPR) for hemorrhage. Recent years, more and more researches indicated that it was feasible of thrombolytic therapy in CPR, as well as relatively safe and effective .This article reviews evidences and clinical applications of thrombolytic therapy in CPR, and conducts evaluations about its benefits and risks.

Key words: cardiac arrest, cardiopulmonary re-suscitation, thrombolytic therapy

CLC Number:

R605.974

JIANG Ya-bin, WANG Zhi-gang. Application progress of thrombolytic therapy in cardiopulmonary resus-citation[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(8): 951-954.

References

[1] Guibert JJ.The world health report 2002-reducing risks, promoting healthy life[J] .Educ Health(Abingdon), 2003, 16(2):230.
[2] Kliegel A, Losert H, Sterz F, et al.Cold simple intrave-nous infusions preceding special endovascular cooling for faster induction of mild hypothermia after cardiac arrest-a feasibility study[J] .Resuscitation, 2005, 64(3):347-551.
[3] Madl C, Kramer L, Domanovits H, et al.Improved out-come prediction in unconscious cardiac arrest survivors with sensory evoked potentials compared with clinical as-sessment[J] .Crit Care Med, 2000, 28(3):721-726.
[4] Bottiger BW, Martin E.Thrombolytic therapy during car-diopulmonary resuscitation and the role of coagulation acti-vation after cardiac arrest[J] .Curr Opin Crit Care, 2001, 7(3):176-183.
[5] Lederer W, Lichtenberger C, Pechlaner C, et al.Recom-binant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest[J] .Resuscitation, 2001, 50(1):71-76.
[6] Engelstein ED, ZipesDP.Sudden cardiac death[M] Al-exander RW, Schlant RC, Fuster V, et al.The Heart, Arteries and Veins.New York, NY:McGraw-Hill, 1998: 1081-1112.
[7] Spaulding CM, Joly LM, Rosenberg A, et al.Immediate coronary angiography in survivors of out -of -hospital cardiac arrest[J] .N Engl J Med, 1997, 336(23):1629-1633.
[8] Davies MJ.An atomic features in victims of sudden coro-nary death:coronary artery pathology[J] .Circulation, 1992, 85(Suppl 1):19-24.
[9] Schmermund A, Schwartz RS, Adamzik M, et al.Coro-nary atherosclerosis in unheralded sudden coronary death under age 50:histo-pathologic comparison with“ healthy” subjects dying out -of -hospital[J] .Atherosclerosis, 2001, 155(2):499-508.
[10] Adrie C, Adib-Conquy M, Laurent I, et al.Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest:implication of the protein C anticoagulant pathway[J] .J Am Coll Cardiol, 2005, 46(1):21-28.
[11] Bottiger BW, Motsch J, Bohrer H, et al.Activation of blood coagulation after cardiac arrest is not balanced ade-quately by activation of endogenous fibrinolysis[J] .Circu-lation, 1995, 92(9):2572-2578.
[12] Gando S, Kameue T, Nanzaki S, et al.Massive fibrin formation with consecutive impairment of fibrinolysis in pa-tients with out of hospital cardiac arrest[J] .Thromb Hae-most, 1997, 77(2):278-282.
[13] Fischer M, Bottiger BW, Popov-Cenic S, et al.No-reflow after cardiac arrest[J] .Intensive Care Med, 1995, 21(2):132-141.
[14] Fischer M, Bottiger BW, Popov-Cenic S, et al.Throm-bolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat[J] .Intensive Care Med, 1996, 22(11):1214-1223.
[15] 杨坤, 陈寿权, 李章平, 等.心肺复苏后血浆组织因子和组织因子途径抑制物的变化及银杏达莫的干预研究[J] .中国急救医学, 2008, 28(4):322-324.
[16] 蔺际龙天, 廖晓星, 李欣, 等.抗凝溶栓药物对家兔复苏时微循环的影响[J] .中国急救复苏与灾害医学杂志, 2008, 3(7):399-402.
[17] 廖晓星, 蔺际龙天, 李欣, 等.抗凝溶栓药物对家兔复苏时血流动力学的影响[J] .中国急救医学, 2008,28(8):724-727.
[18] 康舟军, 霍正禄, 曹晖.心肺复苏后血清细胞因子与脑组织的变化以及巴曲酶对其影响的实验室研究[J] .中国急救医学, 2009, 29(5):432-437.
[19] Spöhr F, Böttiger BW.Thrombolytics in CPR.Current advantages in cardiopulmonary resuscitation[J] .Minerva Anestesiol, 2005, 71(6):291-296.
[20] Bottiger BW, Bode C, Kern S, et al.Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiop-ulmonary resuscitation:a prospective clinical trial[J] . Lancet, 2001, 357(9268):1583-1585.
[21] Lederer W, Lichtenberger C, Pechlaner C, et al.Recom-binant tissue plasminogen activator during cardiopulmonary resuscitationin108 patientswith out-of-hospital cardiac ar-rest[J] .Resuscitation, 2001, 50(1):71-76.
[22] Abu-Laban RB, Christenson JM, Innes GD, et al.Tissue plasminogen activator in cardiac arrest with pulseless elec-trical activity[J] .N Engl J Med, 2002, 347(16):1281-1282.
[23] Böttiger BW, Arntz HR, Chamberlain DA, et al.Throm-bolysis during resuscitation for out-of-hospital cardiac arrest[J] .N Engl JMed, 2008, 359(25):2651-2662.
[24] Fatovich DM, DobbCJ, Clugston RA.A pilot randomised trial of thrombolysis in cardiac arrest(The TICA trial)[J] . Resuscitation, 2004, 61(3):309-313.
[25] 袁晓玲, 党伟, 果应非, 等.早期溶栓治疗在心肺复苏中的作用及其意义[J] .中国急救医学, 2009, 29(1):35-37.
[26] 方伟钧, 田昕, 陈礼平.心肺复苏中溶栓治疗的探讨[J] .中国急救医学, 2008, 28(10):953-954
[27] 王以照, 王英杰, 李冬梅.尿激酶对心肺复苏成功率的影响[J] .徐州医学院学报, 2008, 28(2):103-105.
[28] Spöhr F, Amtz HR, Bluhmki E, et al.Internationalmul-ticentre trial protocol to assessthe efficacy and safety of te-necteplase during cardiopulmonary resuscitation in patients with out -of -hospital cardiac arrest:The Thrombolysis in Cardiac Arrest (TROICA) Study[J] .Eur J Clin Inves, 2005, 35(5):315-323.
[29] 李欣, 廖晓星, 荆小莉, 等.心肺复苏过程中进行溶栓治疗的 Meta 分析[J] .中华急诊医学杂志, 2005,14(8):651-654.
[30] 徐昌盛, 刘文革.急性心肌梗死心肺复苏后溶栓疗效与安全性分析[J] .中国急救医学, 2009, 28(2):113-115